In a rare move, the FDA has threatened to fine a company for failing to report c...
Chinese pharmaceutical companies are developing domestic versions of “miracle” w...
To families whose boys just turned 6, putting them over the line for Sarepta's g...
The proportion of cases found in migrants to Florida has decreased significantly...
Gilead Sciences has entered into partnerships with Tentarix for the development ...
Bluebird bio eyes hattrick of gene therapy approvals, with a PDUFA date for sick...
The merger will be finalised today, transforming the businesses into a single co...
Eyenovia hopes for near-term revenue from the licencing deal, with APP13007’s PD...
Amicus’ Pombiliti and Opfolda received approval from the UK MHRA through the Inn...
The Phase IIb trial in idiopathic pulmonary fibrosis for GB0139 did not meet its...
Illumina has faced a series of legal challenges to its 2021 acquisition of Grail...
AGC has entered into an agreement with Asahi Kasei to produce clinical drug subs...
Precision BioSciences and Imugene have concluded a strategic transaction for wor...
Explore Capmatic's advanced solutions in solid dosage packaging, tailor-made for...
Paradoxically, medicines under the U.S. drug-pricing system are both too cheap a...
The Senate might hold up the nomination of Monica Bertagnolli for NIH director f...
